RESHAPING ANTICOAGUALTION CLINICS IN THE ERA OF NEW ORAL ANTICOAGULANTS

Antoine Cherfan, Pharm.D. Manager of Pharmacotherapy Services  Cleveland clinic Abudhabi.UAE

 

Since its discovery during the first half of the 20th century and over 60 years, warfarin along with other vitamin K antagonists has remained the only oral anticoagulant available to patients at risk for thromboembolism.

Anticoagulation Clinics emerged as services specialized in the management of patients on anticoagulant treatment particularly warfarin with various models to monitor and optimize the therapy of this high alert medication. With the emergence of the new oral anticoagulants and increased evidence showing similar or better safety profile without the need for monitoring, warfarin is set to be part of the past. With that a new role for anticoagulation clinics is emerging to meet the evolving needs of patients with the newer agents making use of all available technologies from telemedicine and electronic medical systems.

 

Objectives:

  • Describe the development of anticoagulation therapy since discovery
  • Highlight the role and future prospects of the new agents in the different disease aetiologies

Identify the future functions of anticoagulation clinics in the new Era of anticoagulation